Seeking Alpha

ANTB
  AntriaBio, Inc. - OTCQB

8/21/2014, 4:24 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ANTB vs. ETF Alternatives
Company Description
AntriaBio is a biopharmaceutical company focused on developing novel therapeutic products for the diabetes market. Our development strategy combines FDA-approved pharmaceutical agents with our proprietary delivery technology. Our lead product candidate is AB101, an injectable once-a-week basal... More